• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cochrane系统评价和关于尿石症的原始研究中健康公平性考量的评估

Assessment of health equity consideration in Cochrane systematic reviews and primary studies on urolithiasis.

作者信息

Basirat Reyhane, Soleimani Sevim, Shakiba Behnam, Maghsoudi Robab

机构信息

School of Medicine Iran University of Medical Sciences Tehran Iran.

Student Research Committee, Faculty of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran.

出版信息

Health Sci Rep. 2023 Feb 24;6(2):e1133. doi: 10.1002/hsr2.1133. eCollection 2023 Feb.

DOI:10.1002/hsr2.1133
PMID:36846534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9953072/
Abstract

BACKGROUND AND AIMS

Health injustice is defined as "unnecessary, preventable, unjustified and unfair health differences." One of the most important scientific sources on the prevention and management of urolithiasis are Cochrane reviews in this field. Given that the first step in eliminating health injustice is to identify the causes, the aim of the present study was to evaluate equity considerations in Cochrane reviews and the included primary studies on urinary stones.

METHODS

Cochrane reviews on kidney stones and ureteral stones were searched through the Cochrane Library. The included clinical trials in each of the reviews published after 2000 were also collected. Two different researchers reviewed all the included Cochrane reviews and primary studies. The researchers reviewed each PROGRESS criteria independently (P: place of residence, R: race/ethnicity/culture, O: occupation, G: gender, R: religion, E: education, S: socioeconomic status, S: social capital and networks). The geographical location of the included studies was categorized as low-income, middle-income and high-income countries, based on the World Bank income criteria. Each PROGRESS dimension was reported for both the Cochrane reviews and the primary studies.

RESULTS

In total, 12 Cochrane reviews and 140 primary studies were included in this study. None of the included Cochrane reviews had specifically mentioned the PROGRESS framework in the Method section whereas gender distribution and place of residence were reported in two and one reviews, respectively. In 134 primary studies at least one item of PROGRESS was reported. The most frequent item was gender distribution, followed by place of residence.

CONCLUSION

According to the results of this study, the authors of Cochrane systematic reviews on urolithiasis, and researchers who have conducted such trials, have rarely considered health equity dimensions when designing and performing their studies. Therefore, researchers worldwide should be motivated to study populations from low-income countries with low socioeconomic status in addition to different cultures, ethnicities, and so forth. Furthermore, RCT reporting guidelines such as CONSORT should include health equity dimensions and the editors and reviewers of scientific journals should encourage researchers to further emphasize on health equity in their studies.

摘要

背景与目的

健康不公正被定义为“不必要、可预防、不合理且不公平的健康差异”。关于尿石症预防与管理的最重要科学来源之一是该领域的Cochrane系统评价。鉴于消除健康不公正的第一步是找出原因,本研究的目的是评估Cochrane系统评价及其中纳入的关于尿路结石的原始研究中的公平性考量。

方法

通过Cochrane图书馆检索关于肾结石和输尿管结石的Cochrane系统评价。还收集了2000年后发表的各系统评价中纳入的临床试验。两名不同的研究人员对所有纳入的Cochrane系统评价和原始研究进行了审查。研究人员独立审查每个PROGRESS标准(P:居住地,R:种族/民族/文化,O:职业,G:性别,R:宗教,E:教育程度,S:社会经济地位,S:社会资本和网络)。根据世界银行的收入标准,将纳入研究的地理位置分为低收入、中等收入和高收入国家。报告了Cochrane系统评价和原始研究的每个PROGRESS维度。

结果

本研究共纳入12篇Cochrane系统评价和140项原始研究。纳入的Cochrane系统评价中没有一篇在方法部分特别提及PROGRESS框架,而分别有两篇和一篇系统评价报告了性别分布和居住地。在134项原始研究中,至少报告了一项PROGRESS项目。最常报告的项目是性别分布,其次是居住地。

结论

根据本研究结果,关于尿石症的Cochrane系统评价的作者以及进行此类试验的研究人员在设计和开展研究时很少考虑健康公平维度。因此,除了不同文化、种族等群体外,全球研究人员应积极研究社会经济地位较低的低收入国家的人群。此外,诸如CONSORT等随机对照试验报告指南应纳入健康公平维度,科学期刊的编辑和审稿人应鼓励研究人员在其研究中进一步强调健康公平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bac/9953072/a1cdff81fa8a/HSR2-6-e1133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bac/9953072/a1cdff81fa8a/HSR2-6-e1133-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bac/9953072/a1cdff81fa8a/HSR2-6-e1133-g001.jpg

相似文献

1
Assessment of health equity consideration in Cochrane systematic reviews and primary studies on urolithiasis.Cochrane系统评价和关于尿石症的原始研究中健康公平性考量的评估
Health Sci Rep. 2023 Feb 24;6(2):e1133. doi: 10.1002/hsr2.1133. eCollection 2023 Feb.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
A review of health equity considerations in Cochrane reviews of lifestyle interventions for cardiovascular health in adults.Cochrane系统评价中关于成人心血管健康生活方式干预的健康公平性考量综述
J Clin Epidemiol. 2024 Dec;176:111546. doi: 10.1016/j.jclinepi.2024.111546. Epub 2024 Sep 27.
4
Is health equity considered in systematic reviews of the Cochrane Musculoskeletal Group?Cochrane肌肉骨骼组的系统评价中是否考虑了健康公平性?
Arthritis Rheum. 2008 Nov 15;59(11):1603-10. doi: 10.1002/art.24206.
5
Equity issues were not fully addressed in Cochrane human immunodeficiency virus systematic reviews.Cochrane关于人类免疫缺陷病毒的系统评价中未充分探讨公平性问题。
J Clin Epidemiol. 2017 Jan;81:96-100. doi: 10.1016/j.jclinepi.2016.09.008. Epub 2016 Sep 29.
6
Is equity considered in systematic reviews of interventions for mitigating social isolation and loneliness in older adults?系统评价干预措施以减轻老年人社会隔离和孤独感时是否考虑公平性?
BMC Public Health. 2022 Dec 1;22(1):2241. doi: 10.1186/s12889-022-14667-8.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Equity was rarely considered in Cochrane Eyes and Vision systematic reviews and primary studies on cataract.在 Cochrane 眼部和视力系统评价以及白内障的原始研究中,很少考虑公平性。
J Clin Epidemiol. 2020 Sep;125:57-63. doi: 10.1016/j.jclinepi.2020.04.024. Epub 2020 May 7.
9
How Is Health Equity Assessed in Cochrane Musculoskeletal Reviews?考科蓝肌肉骨骼系统评价中如何评估健康公平性?
J Rheumatol. 2022 Dec;49(12):1379-1384. doi: 10.3899/jrheum.220169. Epub 2022 Aug 15.
10
Assessing evidence of interventions addressing inequity among migrant populations: a two-stage systematic review.评估干预措施在解决移民人群中不平等问题方面的证据:两阶段系统评价。
Int J Equity Health. 2019 May 6;18(1):64. doi: 10.1186/s12939-019-0970-x.

引用本文的文献

1
Consideration of health inequity in systematic reviews and primary studies on risk factors for hearing loss.在关于听力损失风险因素的系统评价和原始研究中对健康不平等的考量。
Cochrane Evid Synth Methods. 2024 Apr 3;2(4):e12052. doi: 10.1002/cesm.12052. eCollection 2024 Apr.

本文引用的文献

1
Usefulness of Cochrane Reviews in Clinical Guideline Development-A Survey of 585 Recommendations.Cochrane 综述在临床指南制定中的作用——对 585 项推荐意见的调查。
Int J Environ Res Public Health. 2022 Jan 7;19(2):685. doi: 10.3390/ijerph19020685.
2
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.成人肾或输尿管结石冲击波碎石术后使用α受体阻滞剂。
Cochrane Database Syst Rev. 2020 Nov 12;11(11):CD013393. doi: 10.1002/14651858.CD013393.pub2.
3
Reporting of health equity considerations in cluster and individually randomized trials.
报告群组随机和个体随机试验中的健康公平性考虑因素。
Trials. 2020 Apr 3;21(1):308. doi: 10.1186/s13063-020-4223-5.
4
Water for preventing urinary stones.预防尿路结石的水。
Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD004292. doi: 10.1002/14651858.CD004292.pub4.
5
Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi.输尿管镜检查治疗肾和输尿管结石时输尿管支架置入与不置入的比较
Cochrane Database Syst Rev. 2019 Feb 6;2(2):CD012703. doi: 10.1002/14651858.CD012703.pub2.
6
Internal and external validity: can you apply research study results to your patients?内部效度和外部效度:你能将研究结果应用于你的患者吗?
J Bras Pneumol. 2018 May-Jun;44(3):183. doi: 10.1590/S1806-37562018000000164.
7
Medical and surgical interventions for the treatment of urinary stones in children.儿童尿路结石治疗的医学及外科干预措施。
Cochrane Database Syst Rev. 2018 Jun 2;6(6):CD010784. doi: 10.1002/14651858.CD010784.pub2.
8
Alpha-blockers as medical expulsive therapy for ureteral stones.α受体阻滞剂作为输尿管结石的药物排石疗法
Cochrane Database Syst Rev. 2018 Apr 5;4(4):CD008509. doi: 10.1002/14651858.CD008509.pub3.
9
Medical and dietary interventions for preventing recurrent urinary stones in children.预防儿童复发性尿路结石的医学和饮食干预措施。
Cochrane Database Syst Rev. 2017 Nov 9;11(11):CD011252. doi: 10.1002/14651858.CD011252.pub2.
10
Citrate salts for preventing and treating calcium containing kidney stones in adults.用于预防和治疗成人含钙肾结石的柠檬酸盐。
Cochrane Database Syst Rev. 2015 Oct 6;2015(10):CD010057. doi: 10.1002/14651858.CD010057.pub2.